RecruitingNot Applicable

Congenital Hepatic Fibrosis and Autosomal Recessive Polycystic Kidney Disease in Children at Sohag University Hospital

Egypt30 participantsStarted 2024-08-01

Plain-language summary

polycystic kidney disease is aherditary disorder characterized by the formation of numerous fluid filled cysts in the kidneys which can lead to progressive renal impairment PKDencompasses aspectrum of disorders with autosomal dominant polycystic kidneydisease and autosomal recessive polycystic kidney disease being the two main types

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * pediatric patients aged 0-18 years both male and female patients Exclusion Criteria: * patients whose guardians dont provide informed consent patients who are not complient with follow up vists and data collection protocols

What they're measuring

incidence of congenital hepatic fibrosis in patient with autosomal recessive polycyctic kidney disease

Timeframe: 12 months

Trial details

NCT IDNCT06601829

SponsorSohag University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2025-08-01

View on ClinicalTrials.gov More Congenital Hepatic Fibrosis and Autosomal Recessive Polycystic Kidney Disease in Children at Sohag University Hospital trials